Norry Elliot

Avg. Two Year Performance

No purchase track record

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	2%	3%	(7%)	0%	0%
Sale Success Rate	1 of 3	1 of 3	0 of 3	0 of 3	0 of 3

Adaptimmune Therapeutics plc

Drugs » Biotechnology

Chief Medical Officer:

Holdings: 19.26K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--